New Zealand markets open in 5 hours 2 minutes

Cano Health, Inc. (CANOQ)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.2750-0.0005 (-0.18%)
As of 10:59AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.31M
Enterprise value 1.22B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)1.55
Enterprise value/revenue 0.39
Enterprise value/EBITDA -1.53

Trading information

Stock price history

Beta (5Y monthly) -0.49
52-week change 3-99.78%
S&P500 52-week change 325.59%
52-week high 3174.0000
52-week low 30.1000
50-day moving average 30.2689
200-day moving average 319.6051

Share statistics

Avg vol (3-month) 327.91k
Avg vol (10-day) 315.95k
Shares outstanding 54.76M
Implied shares outstanding 65.41M
Float 83.31M
% held by insiders 129.42%
% held by institutions 116.82%
Shares short (12 Jan 2024) 4577.29k
Short ratio (12 Jan 2024) 42.03
Short % of float (12 Jan 2024) 417.81%
Short % of shares outstanding (12 Jan 2024) 416.00%
Shares short (prior month 15 Dec 2023) 4535.56k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 303 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -18.94%
Operating margin (ttm)-10.08%

Management effectiveness

Return on assets (ttm)-18.95%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.14B
Revenue per share (ttm)1,139.30
Quarterly revenue growth (yoy)5.20%
Gross profit (ttm)N/A
EBITDA -339.93M
Net income avi to common (ttm)-594.42M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)93.92M
Total cash per share (mrq)19.86
Total debt (mrq)1.31B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.13
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-129.05M
Levered free cash flow (ttm)29.94M